Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...
Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...
WATERTOWN, Mass, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ...
Sweden 10 Year Government Bond 0.0590 2.1538% ...
Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback